Molecular targets in lymphomas.
A large proportion of patients with lymphomas are curable with standard chemotherapy. There is a plateau, however, in cure rate with chemotherapy alone. Advances in molecular biology have led to a better understanding of the pathogenesis of lymphomas. This article provides examples of how molecular therapy is going to change the treatment of lymphomas.
Psyrri
Amanda
A
Yale University School of Medicine, New Haven, CT, USA.
Economopoulos
Theofanis
T
D000818:Animals; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism*